Dingdang Health Technology Group Ltd. (HKG:9886)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.7500
-0.0100 (-1.32%)
Jul 31, 2026, 3:03 PM HKT

HKG:9886 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
4,8884,8884,6694,8574,3293,679
Revenue Growth
3.38%4.68%-3.86%12.19%17.68%65.07%
Gross Profit
1,7241,7241,5381,5111,4501,162
Operating Income
-53.44-53.44-215.18-278.25-326.42-660.65
Net Income
-49.02-49.02-376.5-225.81-2,833-1,578
Earnings Per Share
-0.04-0.04-0.28-0.17-3.37-3.31
EPS Growth
------

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Pharmaceutical and Healthcare Business
4,7454,7454,5404,7184,2023,561
Others
143.19143.19129.46139.21127.46117.35
Total
4,8884,8884,6694,8574,3293,679

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,0891,0891,2181,3291,3481,553
Total Debt
281.81281.81152.61140.21163.144,808
Net Cash (Debt)
807.33807.331,0651,1891,185-3,255
Net Cash Growth
-26.35%-24.22%-10.41%0.38%--
Net Cash Per Share
0.620.620.810.891.41-6.82

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
136.82136.82-11.35-5.24-237.87-295.49
Capital Expenditures
-26.33-26.33-17.13-13.86-17.7-20.47
Free Cash Flow
110.49110.49-28.48-19.1-255.57-315.96
Free Cash Flow Growth
28.40%-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
35.26%35.26%32.95%31.10%33.49%31.60%
Operating Margin
-1.09%-1.09%-4.61%-5.73%-7.54%-17.96%
Pretax Margin
-0.63%-0.63%-7.93%-4.55%-65.42%-43.00%
Profit Margin
-1.00%-1.00%-8.06%-4.65%-65.45%-42.90%
FCF Margin
2.26%2.26%-0.61%-0.39%-5.90%-8.59%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
21.5448.08----
P/FCF Ratio
7.6211.40----
PS Ratio
0.170.260.130.503.19-